Addition of alternative testing location for a device component
| Device | Abbott RealTime HCV Genotype II |
| Generic Name | Assay, Genotyping, Hepatitis C Virus |
| Applicant | ABBOTT MOLECULAR |
| Date Received | 2021-02-05 |
| Decision Date | 2021-03-05 |
| PMA | P120012 |
| Supplement | S019 |
| Product Code | OBF |
| Advisory Committee | Microbiology |
| Supplement Type | 30-day Notice |
| Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | ABBOTT MOLECULAR 1300 East Touhy Avenue des Plaines, IL 60018 |
Supplemental Filings
| Supplement Number | Date | Supplement Type |
|---|
| P120012 | | Original Filing |
| S019 |
2021-02-05 |
30-day Notice |
| S018 |
2019-04-10 |
30-day Notice |
| S017 |
2018-05-25 |
30-day Notice |
| S016 |
2017-06-27 |
135 Review Track For 30-day Notice |
| S015 |
2016-12-01 |
30-day Notice |
| S014 |
2016-06-01 |
30-day Notice |
| S013 |
2016-04-20 |
30-day Notice |
| S012 |
2016-03-28 |
30-day Notice |
| S011 |
2016-03-25 |
30-day Notice |
| S010 |
2015-12-16 |
Real-time Process |
| S009 |
2015-07-29 |
Real-time Process |
| S008 | | |
| S007 |
2015-03-26 |
30-day Notice |
| S006 |
2014-11-10 |
30-day Notice |
| S005 |
2014-10-24 |
30-day Notice |
| S004 |
2014-08-28 |
30-day Notice |
| S003 |
2013-07-23 |
30-day Notice |
| S002 |
2013-07-15 |
30-day Notice |
| S001 |
2013-07-12 |
30-day Notice |
NIH GUDID Devices